Related references
Note: Only part of the references are listed.Molecular targeted therapy: A new avenue in glioblastoma treatment
Oula El Atat et al.
ONCOLOGY LETTERS (2023)
Updates in the Management of Recurrent Glioblastoma Multiforme
Hanuman Prasad Prajapati et al.
JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY (2023)
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I. Tsien et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Multiple direction needle-path planning and inverse dose optimization for robotic low-dose rate brachytherapy
Philipp Aumueller et al.
ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK (2022)
Intratumoral oncolytic herpes virus G47 increment for residual or recurrent glioblastoma: a phase 2 trial
Tomoki Todo et al.
NATURE MEDICINE (2022)
Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial
Kris Smith et al.
NEURO-ONCOLOGY (2022)
First clinical implementation of GammaTile permanent brain implants after FDA clearance
Clara Ferreira et al.
BRACHYTHERAPY (2021)
Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy
Shearwood McClelland et al.
BRACHYTHERAPY (2021)
Radiosurgery for Glioblastoma
Adomas Bunevicius et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2021)
The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy
Lin Zheng et al.
FRONTIERS IN ONCOLOGY (2021)
Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma
Aleksey Krivoshapkin et al.
Surgical Neurology International (2021)
Limited recurrence distance of glioblastoma under modern radiotherapy era
Ziwei Tu et al.
BMC CANCER (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Therapeutic applications of radioactive sources: from image-guided brachytherapy to radio-guided surgical resection
Leah R. Dickhoff et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy
Hui Xue et al.
CANCERS (2021)
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Annette M. Molinaro et al.
JAMA ONCOLOGY (2020)
A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer
Johnna Perdrizet et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
GammaTile®: Surgically targeted radiation therapy for glioblastomas
Dominic J. Gessler et al.
FUTURE ONCOLOGY (2020)
Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB)
Jaroslaw T. Hepel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control
A. Gabriella Wernicke et al.
BRACHYTHERAPY (2020)
A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma
Xiangmeng He et al.
RADIATION ONCOLOGY (2020)
Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry
Ali M. Saeed et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Denise Fabian et al.
CANCERS (2019)
Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
Alessio D'Alessio et al.
CANCERS (2019)
Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database
Jiri Bartek et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
Farasat Kazmi et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery
Mayur Sharma et al.
JOURNAL OF NEUROSURGERY (2019)
Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas
David G. Brachman et al.
JOURNAL OF NEUROSURGERY (2019)
Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme
Georgios Chatzikonstantinou et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2019)
Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
Sherise D. Ferguson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Dose-dense temozolomide for recurrent high-grade gliomas: a single-center retrospective study
Catherine R. Garcia et al.
MEDICAL ONCOLOGY (2018)
CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a20-year single-institute experience
Georgios Chatzikonstantinou et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2018)
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience
Brandon S. Imber et al.
NEUROSURGERY (2017)
High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review
Hannah Buckley et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Expert consensus workshop report: Guideline for three-dimensional printing template-assisted computed tomography-guided 125I seeds interstitial implantation brachytherapy
Junjie Wang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2017)
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R. Perry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis
Sergey V. Roussakow
BMJ OPEN (2017)
Advancements in brachytherapy
Kari Tanderup et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection
Florian Ringel et al.
NEURO-ONCOLOGY (2016)
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naive patients
Christine Jungk et al.
BMC CANCER (2016)
Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas
Christoph Schwartz et al.
ACTA NEUROCHIRURGICA (2015)
Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experience
Shaakir Hasan et al.
FRONTIERS IN ONCOLOGY (2015)
Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases
Philipp Kickingereder et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm
Eleftherios Archavlis et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy
Eleftherios Archavlis et al.
NEUROLOGICAL RESEARCH (2014)
Response Patterns of Recurrent Glioblastomas Treated With Tumor-Treating Fields
Josef Vymazal et al.
SEMINARS IN ONCOLOGY (2014)
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma
J. Dawn Waters et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme
Eleftherios Archavlis et al.
BMJ OPEN (2013)
Patterns of care for brachytherapy in Europe: updated results for Spain
Ferran Guedea et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article
Orin Bloch et al.
JOURNAL OF NEUROSURGERY (2012)
PATTERN OF FAILURE AFTER LIMITED MARGIN RADIOTHERAPY AND TEMOZOLOMIDE FOR GLIOBLASTOMA
Mark W. McDonald et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
Shannon E. Fogh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IMAGING AFTER GLIASITE BRACHYTHERAPY: PROGNOSTIC MRI INDICATORS OF DISEASE CONTROL AND RECURRENCE
Lawrence Kleinberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme
Pantaleo Romanelli et al.
NEUROSURGICAL FOCUS (2009)
An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme
L. Pellettieri et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme
Borimir J. Darakchiev et al.
JOURNAL OF NEUROSURGERY (2008)
Tumour surface area as a prognostic factor in primary and recurrent glioblastoma irradiated with Ir-192 implantation
Andrzej Lebioda et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2008)
CT-Guided interstitial HDR Brachytherapy for recurrent glioblastoma Multiforme -: Long-term results
Nikolaos Tselis et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2007)
GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis
AJ Gabayan et al.
NEUROSURGERY (2006)
Treatment of recurrent glioblastoma multiforme with gliasite brachytherapy
TA Chan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme
DA Larson et al.
NEURO-ONCOLOGY (2004)
Brachytherapy of glioblastoma recurring in previously irradiated territory: Predictive value of tumor volume
JM Simon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05
E Shaw et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme
S Patel et al.
NEUROSURGERY (2000)
Share Paper
